Patent · US Active

Compositions and methods of treating cardiac fibrosis with ifetroban

US9693998B2 · kind B2 · utility

3Cited by
16References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 18, 2015
Grant dateJul 4, 2017
Priority date
Expiry dateMay 18, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.